EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (Yesterday)
Upcoming ASCCT & ESTIV webinar: Automated and Integrated Analysis Workflow for Adverse Outcome Pathway Identificati… https://t.co/7QjUWqiKmB
Edelweiss Connect (1 week ago)
RT @barryhardy: Integrating evidence to evaluate and remove allergy issues of compounds - come discuss with us at @EdelweissConn Edelweiss…
Edelweiss Connect (2 weeks ago)
Extensive domain knowledge helps Edelweiss Connect create optimal solutions not only on how to store data but also… https://t.co/QWYVYaMiyS
Edelweiss Connect (2 weeks ago)
Discover valuable data connections from different sources, integrate with your own data and share the enhanced reso… https://t.co/ODTFpFBDNc
Edelweiss Connect (2 weeks ago)
Come see our new EdelweissData™ next week at #BioIT19 Booth 236. Developed within the context of… https://t.co/lR3ovhRGKI

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 633 29 78
  • Email: info@edelweissconnect.com

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA
  • Phone: +1 503 2014 725
  • Email: info@edelweissconnect.com